US naturals firm ChromaDex has announced the completion of an animal skincare study of pterostilbene, which the firm says shows that the substance prevents skin damage from UV exposure.
ChromaDex completes pterostilbene UV trial
US naturals firm ChromaDex has announced the completion of an animal skincare study of pterostilbene, which the firm says shows that the substance prevents skin damage from UV exposure
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
Is ‘longevity washing’ beauty's next big issue?
Longevity science is changing the beauty game, shifting focus from symptom correction to root cause intervention. However, with such a rise, could the category fall foul to ‘longevity washing’ – products marketed as formulated with the science when they are not. CB investigates…
Ingredients
What drives the rising demand for cosmetic grade Azelaic Acid?
Azelaic acid has a long history in dermatology as a versatile therapeutic agent, as it addresses a spectrum of skin concerns, making it a valuable addition to cosmetic formulations. In recent years, demand for azelaic acid has expanded beyond dermatology and is increasingly featured in over-the-counter skincare and prestige beauty launches. What drives this growth in the amount of newly launched cosmetic products that contain azelaic acid?
Ingredients
Meet the speakers: 2026 Anti-Ageing Skin Care Conference agenda revealed
Featuring speakers from leading companies such as Unilever, A*STAR Skin Research Lab, Procter & Gamble and others, the biennial Anti-Ageing Skin Care Conference returns with another exciting year of thought leaders who are driving innovation in the skin-care and science industry
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.